Reditux 100 (Rituximab) 100mg/10ml

Reditux 100 (Rituximab 100mg/10ml) is an injectable biologic used for immune system modulation. This monoclonal antibody therapy supports treatment of autoimmune conditions and certain cancers. Ideal for patients seeking targeted immunotherapy solutions.

Strength

100mg/10ml

Pack Size

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Reditux 100 is primarily used to modulate the immune system in autoimmune disorders like rheumatoid arthritis and vasculitis. It is also prescribed for certain blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. Patients often ask what is rituximab used for in these broad therapeutic areas.

Side Effects

Reditux 100 works by targeting CD20-positive B cells, helping reduce inflammation and abnormal cell growth. Users may notice improved symptoms over time as the immune response is regulated. Effects vary and should be monitored by a healthcare professional.

Precautions & Warnings

Store Reditux 100 refrigerated between 2°C and 8°C and protect from light. Do not freeze or shake vigorously. Always check the solution for particles or discoloration before use. Follow healthcare provider instructions for handling and disposal.

Avoid Interactions

Reditux 100 may interact with other immunosuppressants or live vaccines, potentially increasing infection risk. Caution is advised when combining with medications affecting the immune system. Discuss all current medications with your doctor before starting therapy.

Frequently Asked Questions

Rituximab is used to treat autoimmune conditions like rheumatoid arthritis by targeting B cells that contribute to inflammation.

Rituximab is a prescription medication; purchase only from licensed pharmacies with valid prescriptions for safety.

Response times vary; some patients notice effects within weeks, while others may take longer. Regular monitoring is recommended.

Rituximab is a targeted therapy, not a traditional chemotherapy, but it is used in cancer treatment protocols.

Common effects may include infusion reactions, infections, or low blood cell counts; report any unusual symptoms to your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.